5,7-dihydroxytryptamine has been researched along with Amphetamine-Related Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ | 1 |
1 other study(ies) available for 5,7-dihydroxytryptamine and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Disease Models, Animal; Hippocampus; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome | 2014 |